[Imaging of glial cells by positron-emitted peripheral benzodiazepine receptor ligands]
- PMID: 16637592
[Imaging of glial cells by positron-emitted peripheral benzodiazepine receptor ligands]
Abstract
Recently, it has been indicated that glial cells play as important role in the development of neurodegenerative disorders. Expression of peripheral benzodiazepine receptor (PBR) has higher localization in the glial cells than in the neural cells, and is a noticeable marker for gliosis produced by neurodegeneration. In vivo imaging of PBR has been attempted by [11C]PK11195 positron emission tomography (PET), and it has been documented that the [11C]PK11195 binding potential increases in various neurodegenerative disorders such as Alzheimer's disease and stroke. Furthermore, we have succeeded in developing new positron ligands [11C]DAA1106 and [18F]fluoroethyl-DAA1106 for visualization of PBRs, which have higher accumulation in the brain than [11C]PK11195. We concluded that PET imaging by PBR ligands is useful for diagnosis of neurodegenerative disorders.
Similar articles
-
A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.J Neurochem. 2007 Sep;102(6):2118-2131. doi: 10.1111/j.1471-4159.2007.04690.x. Epub 2007 Jun 7. J Neurochem. 2007. PMID: 17555551
-
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.J Neurol Sci. 2008 Jan 15;264(1-2):9-17. doi: 10.1016/j.jns.2007.07.018. Epub 2007 Aug 28. J Neurol Sci. 2008. PMID: 17727889 Clinical Trial.
-
Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain.Synapse. 2004 Jun 15;52(4):283-91. doi: 10.1002/syn.20027. Synapse. 2004. PMID: 15103694
-
PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders.Curr Pharm Des. 2008;14(31):3297-315. doi: 10.2174/138161208786549443. Curr Pharm Des. 2008. PMID: 19075709 Review.
-
[11C]N-Methyl-N-phenyl-[2-(4-chlorophenyl)-6,8-dichloroimidazo[1,2-a]pyridin-3-yl]acetamide.2008 Oct 8 [updated 2008 Dec 2]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Oct 8 [updated 2008 Dec 2]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641816 Free Books & Documents. Review.